Rituxim

Product Overview

Rituxim (Rituximab) is a sterile, clear, colorless, preservative-free liquid concentrate formulated at a concentration of 10 mg/mL for intravenous (IV) administration. As a CD20-directed cytolytic monoclonal antibody, Rituxim targets and binds selectively to the CD20 antigen on B-lymphocytes, triggering cell lysis.

Available Strength Options:

• 100 mg / 10 mL Single-Dose Vial: Provides fine-tuned precision for custom body surface area (BSA) calculations and modular dosing additions.
• 500 mg / 50 mL Single-Dose Vial: The efficient baseline choice for standard adult oncological and therapeutic treatment protocols.

Key Clinical Indications

• Oncology: Non-Hodgkin’s Lymphoma (NHL) & Chronic Lymphocytic Leukemia (CLL).
• Rheumatology: Moderate-to-severe Rheumatoid Arthritis (RA) alongside Methotrexate.
• Autoimmune Vascular/Dermal: Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Pemphigus Vulgaris (PV).

Cold Chain Logistics & Storage

• Must be stored refrigerated between 2°C and 8°C (36°F and 46°F).
• Protect from direct light; keep enclosed in the original carton until preparation.
• Do not shake or freeze.